Gagnon Securities LLC Vanda Pharmaceuticals Inc. Transaction History

Gagnon Securities LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2017 Feb 13, 2018	SELL	$12.85 - $18.1 $232,983 - $328,171	-18,131 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$15.4 - $18.85 $279,217 - $341,769	18,131	18,131 $325,000

162

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $250M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Gagnon Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gagnon Securities LLC with notifications on news.